Health in AFR 66 indicators covering health for AFR. IndicatorLatest Year10-yr change Rank Total tetanus - number of reported cases 20,578 2025 up 483.1% 2nd Pertussis - number of reported cases 12,202 2025 up 61.3% 13th Infant mortality rate (probability of dying between birth and age 1) 46.32 2024 down 14.0% 2nd Under-five mortality rate 69.9 2024 down 17.8% 1st Maternal mortality ratio 442.12 2023 down 26.5% 1st Number of deaths among children ages 5 to 9 years 281,554 2024 down 8.0% 2nd Mortality rate among children ages 5 to 9 years 8.27 2024 down 23.9% 2nd Number of deaths among adolescents 181,479 2024 up 7.4% 3rd Proportion of population with primary reliance on polluting fuels and 91.9% 2023 down 2.4% 1st Population with primary reliance on polluting fuels and technologies 632.45 2023 up 14.8% 2nd Population with primary reliance on clean fuels and technologies for 55.86 2023 up 62.9% 12th Proportion of population with primary reliance on fuels and 83.2% 2023 down 3.9% 1st Population with primary reliance on fuels and technologies for 572.82 2023 up 13.0% 2nd Prevalence of diabetes, age-standardized 10.52 2022 up 18.5% 13th Prevalence of diabetes, crude 8.58 2022 up 24.5% 12th Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 83.0% 2025 up 6.4% 10th Measles-containing-vaccine first-dose (MCV1) immunization coverage 71.0% 2025 up 4.4% 15th New HIV infections 0.49 2025 down 59.2% 1st BCG immunization coverage among 1-year-olds (%) 82.0% 2025 up 6.5% 15th Mean total cholesterol, crude 4 2018 up 2.6% 16th Mean HDL cholesterol, crude 1.1 2018 unchanged 10th Mean total cholesterol, age-standardized 4 2018 unchanged 16th Stunting prevalence among children under 5 years of age (%) 31.7% 2024 down 7.6% 2nd Stunting numbers among children under 5 years of age (millions) 59,122 2024 up 6.7% 5th Overweight prevalence among children under 5 years of age (%) 4.2% 2024 up 13.5% 14th Overweight numbers among children under 5 years of age (thousands) 7,740 2024 up 29.9% 8th Adolescent mortality rate 6.02 2021 down 17.9% 1st Incidence of tuberculosis 207 2024 down 31.0% 2nd Deaths due to tuberculosis among HIV-negative people 25 2024 down 49.0% 2nd Domestic private health expenditure (PVT-D) as percentage of current 42.1% 2023 down 3.0% 7th Prevalence of HIV among adults aged 15 to 49 2.9% 2025 down 27.5% 1st Estimated number of people (all ages) living with HIV 26.30 million 2025 up 8.7% 2nd Estimated antiretroviral therapy coverage among people living with HIV 83.0% 2025 up 69.4% 1st Hypertension: effective treatment coverage (controlled hypertension) 10.9% 2019 up 98.2% 15th Hypertension among adults aged 30-79 years, prevalence 35.5 2019 down 4.8% 3rd Hypertension: diagnosis coverage among adults aged 30-79 with 40.0% 2019 up 40.8% 13th Hypertension treatment coverage among adults aged 30-79 with 24.7% 2019 up 42.8% 15th Hypertension: diagnosis coverage among adults aged 30-79 with 42.5% 2019 up 40.3% 13th Hypertension among adults aged 30-79 years, prevalence, crude 31.9 2019 down 5.1% 11th Number of new HIV infections 610,000 2025 down 49.2% 2nd Births attended by skilled health personnel 74.1% 2025 up 25.6% 12th Inactivated first-dose polio vaccine (IPV1) immunization coverage 77.0% 2025 up 285.0% 15th Low birth weight number 5,356 2020 up 9.7% 7th Concentrations of fine particulate matter 33.61 2023 up 11.3% 6th Hepatitis B surface antigen (HBsAg) prevalence 1.4% 2024 down 30.0% 1st Number of deaths attributed to non-communicable diseases, by type of 534,293 2019 up 36.0% 13th Estimated number of MDR/RR-TB incident cases 57,000 2024 down 62.0% 6th Mean hemoglobin level of children aged 6-59 months 105 2019 up 1.9% 12th Number of children aged 6-59 months with anaemia 102,515 2019 up 15.6% 3rd Prevalence of anaemia in children aged 6-59 months 60.2% 2019 down 5.0% 1st Estimated number of malaria cases 264.78 million 2024 up 26.6% 2nd Number of reported cases of poliomyelitis by wild poliovirus 0 2023 down 100.0% 4th Estimated number of children needing antiretroviral therapy based on 1.10 million 2025 down 45.0% 2nd Estimated antiretroviral therapy coverage among children 54 2025 up 50.0% 4th HPV immunization coverage estimates among primary target cohort (9-14) 54.0% 2025 up 980.0% 3rd Smear-positive tuberculosis treatment-success rate 82.0% 2011 up 17.1% 10th Number of indigenous P. falciparum malaria cases 146.86 million 2021 up 238.5% 2nd Number of suspected malaria cases 301.75 million 2021 up 33.0% 2nd Number of malaria positive cases by microscopy 20.44 million 2021 up 17.6% 2nd Number of malaria suspects examined by microscopy 51.21 million 2021 up 17.7% 4th Page 1 of 2 Next →